Reciprocal relationship from EVAX graph: drugs, has become intense. As a result, increasingly high barriers are being erected to the entry of new products. In addition, there can be considerable pres…
Reciprocal relationship from MGNX graph: n exclusive option to license worldwide rights to the research program, upon achievement of a pre-defined preclinical milestone. HIV DART Molecules We conduct…
Reciprocal relationship from MRVI graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from MRVI graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from MRVI g…
Reciprocal relationship from MTNB graph: . The lease impairment charges were included in the impairment charges of other assets line in the consolidated statement of operations and comprehensive loss…
Reciprocal relationship from SMMT graph: commercialize ivonescimab in the United States, Canada, Europe, Japan, Latin America, Middle East and Africa regions (collectively, the “Licensed Territory”).…
Reciprocal relationship from EVAX graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from EVAX graph: ing income in the mid double-digit range. We have initiated a Phase 2 trial,…
Reciprocal relationship from MGNX graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from MGNX graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from MGNX g…
Reciprocal relationship from MTNB graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from MTNB graph: contractors associated with Chemistry and Manufacturing Controls (CMC), pre-…
Reciprocal relationship from SMMT graph: commercialize ivonescimab in the United States, Canada, Europe, Japan, Latin America, Middle East and Africa regions (collectively, the “Licensed Territory”).…
BioNTech SE Debt Obligations
Instrument
Description
Confidence
Evidence
BNTX-DEBT
Debt stack $352.2M
90%
Market cache reports total debt of $352.2M.
BioNTech SE Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for BioNTech SE.
BioNTech SE Ownership
Holder
Name
Confidence
Evidence
BNTX-OWNER-T-ROWE-PRICE-INVESTMENT-MANAGEME
T. Rowe Price Investment Management, Inc.
90%
13F overlay lists T. Rowe Price Investment Management, Inc. as top holder; 274 tracked holders.